Leonard Reyno - Jul 10, 2023 Form 4 Insider Report for C4 Therapeutics, Inc. (CCCC)

Signature
/s/ Jolie M. Siegel, Attorney-in-Fact
Stock symbol
CCCC
Transactions as of
Jul 10, 2023
Transactions value $
$0
Form type
4
Date filed
7/12/2023, 04:06 PM
Next filing
Feb 15, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CCCC Common Stock Award $0 +61.3K $0.00 61.3K Jul 10, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CCCC Stock Option (Right to Buy) Award $0 +276K $0.00 276K Jul 10, 2023 Common Stock 276K $3.50 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock units ("RSUs"). Each RSU represents the contingent right to receive one share of the Issuer's Common Stock upon vesting and settlement. The RSUs shall vest in four equal annual installments following the grant date, with the first installment vesting on July 10, 2024, subject to the Reporting Person's continued service on each such vesting date.
F2 25% of the shares underlying this option shall vest and become exercisable on July 10, 2024, with the remainder vesting in twelve equal quarterly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.